FMR1 and fragile X syndrome: Many IVF programs currently test oocyte donor's FMR1 status to prevent transmission of maternal premutation range (CGGn∼55–200) and/or expansions to full mutations (CGGn>200; fragile X syndrome; FXS) and other associated neuro-psychiatric complications, mostly affecting males [1].